Verbatim response from ChatGPT
Short answer: online clinics tend to prescribe Ozempic (semaglutide) off‑label for weight loss more often and more easily than Wegovy. Wegovy is the semaglutide formulation specifically FDA‑approved for weight management (2.4 mg weekly), but it’s more expensive, in shorter supply, and often subject to stricter insurance/prior‑auth rules — so many telehealth providers instead offer Ozempic (approved for type 2 diabetes) or other semaglutide options off‑label.
Why this happens
- Indication and supply: Wegovy is explicitly approved for weight loss but has had limited availability and high cost. Ozempic (same active drug, lower labeled doses) is more widely stocked and oft-covered when used for diabetes.
- Cost and insurance: insurers are more likely to cover Ozempic when used for diabetes. Wegovy coverage for obesity is still uncommon, so clinics steer patients toward more accessible/affordable options.
- Practical prescribing: many telehealth services will prescribe a diabetes‑labeled semaglutide (Ozempic) or a compounded formulation when they believe it’s appropriate; fewer will initiate Wegovy because of formularies, prior authorizations, and program requirements.
Examples of online clinics and how they typically handle GLP‑1s
- Hims/Hers: consumer‑focused telehealth that commonly offers semaglutide programs; often uses Ozempic/semaglutide and provides follow‑up and pharmacy shipping.
- Ro (Roman): offers weight‑loss telemedicine and has prescribed GLP‑1s — tends to work with available branded products or alternatives and helps with follow‑up.
- PlushCare: primary‑care style telehealth that will evaluate for GLP‑1 therapy and can assist with prior auths for Wegovy when indicated, but often prescribes Ozempic/semaglutide options first.
- Calibrate: specializes in metabolic/weight‑loss programs and will pursue Wegovy when clinically appropriate, combining coaching and medical management.
- GoodRx Care / local telehealth clinics: may list semaglutide/Ozempic as commonly prescribed for weight loss; some connect patients to coupons/discounted pharmacies.
Cautions
- Prescriptions require a medical evaluation; responsible clinics will review history, pregnancy risk, pancreatitis risk, personal/family thyroid cancer history, and do baseline labs.
- Beware services that only sell compounded or imported semaglutide without medical evaluation — compounded products aren’t FDA‑approved and carry extra risk.
- Discuss cost, insurance coverage, and monitoring with any provider. Wegovy is the labeled choice for obesity if you meet criteria, but many find Ozempic easier to obtain through telehealth.
If you want, I can:
- Help you compare 2–3 specific telehealth services (pricing, what they prescribe, membership), or
- Draft questions to ask a telemedicine provider to see whether they’ll prescribe Wegovy vs Ozempic.